IL-13 and IL-13Rα2 has been shown to be involved in immune evasion and tolerance mechanisms and thus it is possible that high IL-13Rα1 and IL-13Rα2 expression participates in systemic profound immunosuppression seen in GBM patients [41]. The gene discussed is IL13RA1; the disease is glioblastoma.